saxagliptin + linagliptin

avoid combo: combo may incr. risk of hypoglycemia, cardiotoxicity, other adverse effects (additive effects, duplicate therapy)

meloxicam + pacritinib

monitor platelets, bleeding or thrombosis s/sx; use lowest effective meloxicam dose, shortest effective tx duration: combo may incr. risk of thromboembolism, GI or other bleeding, including life-threatening (additive effects)